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a b s t r a c t
Mutant H5N1 inﬂuenza viruses have been isolated from humans that have increased human receptor
avidity. We have compared the receptor binding properties of these mutants with those of wild-type
viruses, and determined the structures of their haemagglutinins in complex with receptor analogues.
Mutants from Vietnam bind tighter to human receptor by acquiring basic residues near the receptor
binding site. They bind more weakly to avian receptor because they lack speciﬁc interactions between
Asn-186 and Gln-226. In contrast, a double mutant,Δ133/Ile155Thr, isolated in Egypt has greater avidity
for human receptor while retaining wild-type avidity for avian receptor. Despite these increases in
human receptor binding, none of the mutants prefers human receptor, unlike aerosol transmissible
H5N1 viruses. Nevertheless, mutants with high avidity for both human and avian receptors may be
intermediates in the evolution of H5N1 viruses that could infect both humans and poultry.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).
Introduction
Since 1996, highly pathogenic avian inﬂuenza viruses (H5N1)
have become widespread in poultry and wild birds in Eurasia and
Africa and have caused more than 600 zoonotic human infections
with a death rate approaching 60% (WHO, 2013). Sporadic human
infections continue to occur in countries where H5N1 viruses are
endemic, creating a persistent threat to public health and the
possibility of virus evolution towards efﬁcient transmission in the
human population.
The molecular mechanisms that enable avian inﬂuenza viruses
to cross the species barrier and transmit efﬁciently in humans are
incompletely understood. However, it has been established for the
H1 (1918), H2 (1957) and H3 (1968) pandemic viruses that a
change in the binding speciﬁcity of the virus membrane glycopro-
tein, Haemagglutinin (HA), of avian viruses from a preference for
α-2,3-linked sialo-saccharides (avian receptor) to a preference for
α-2,6-linked sialo-saccharides (human receptor) is a prerequisite
for efﬁcient transmission of avian viruses to humans (Connor et al.,
1994; Matrosovich et al., 2000). Recent H5 transmission studies
also found that a change in the binding preference of the H5
haemagglutinin (HA) from avian receptor to human receptor was
necessary to gain aerosol transmissibility among ferrets, the
widely accepted animal models for inﬂuenza in humans (Chen
et al., 2012; Herfst et al., 2012; Imai et al., 2012; Xiong et al., 2013a;
Zhang et al., 2013). The receptor binding speciﬁcity and transmis-
sibility changes described in all these H5 transmission studies
involved the substitution Gln226Leu in HA (in H3 HA numbering
here and subsequently), a substitution previously correlated
experimentally with the avian to human receptor binding change
(Rogers et al., 1983). Furthermore, avian inﬂuenza viruses of the
H9N2 (Lin et al., 2000) and H7N9 subtypes (Gao et al., 2013; Xiong
et al., 2013b) that have also recently caused human infections have
HAs with leucine at residue 226. An H5 virus in which the
Gln226Leu substitution has occurred has not been isolated from
either birds or from humans. However, surveillance of human H5
viruses has revealed a number of H5 mutants that show enhanced
human receptor binding with HAs that contain other amino acid
substitutions in the receptor binding sub-domain (Chutinimitkul
et al., 2010; Gambaryan et al., 2006; Watanabe et al., 2011; Yamada
et al., 2006). We have studied the mechanisms by which these
mutations alter receptor binding. We have used biolayer inter-
ferometry (BLI) to quantitate receptor binding by HAs identiﬁed in
Southeast Asian clade 1 H5N1 human isolates (Gambaryan et al.,
2006; Yamada et al., 2006) and in mutant clade 2.2 viruses that are
endemic in Egypt. (Watanabe et al., 2011). The results indicate that
two substitutions in H5 clade 1 HA Asn186Lys and Ser227Asn
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signiﬁcantly decreased afﬁnity for avian receptor and that the
former mutation, which introduces a positive charge, enhanced
human receptor binding. The clade 2.2 H5 double mutant Δ133/
Ile155Thr HA also had increased afﬁnity for human receptor but
had little changed afﬁnity for avian receptor. Based on these
results, the human and avian receptor binding modes of H5
HAs bearing the Ser227Asn/Gln196Arg, Asn186Lys, and Δ133/
Ile155Thr substitutions were determined by X-ray crystallography.
Our observations shed light on the molecular basis of the receptor
binding speciﬁcity of the mutants and suggest mechanisms for the
evolution of HA receptor binding properties during H5 virus
infection of humans.
Results
Recombinant H5N1 viruses were generated by replacing the HA
and NA genes of A/Puerto Rico/8/34 (H1N1) (PR8) with corresponding
H5N1 HA and NA genes using a previously described reverse genetics
system (Hoffmann et al., 2000). cDNA clones of HA genes from A/
Vietnam/1194/2004 (H5N1) (VN1194) and A/turkey/Turkey/1/2005
(H5N1) (tyTy) were subcloned into pHW2000 plasmid and their
multibasic cleavage sites (QRERRRKKR) were replaced (QRETR).
Mutant VN1194 viruses containing HA substitutions – Ser227Asn,
Gln196Arg, Asn186Lys, Gly143Arg and selected combinations –
Ser227Asn/Gln196Arg and Asn186Lys/Gly143Arg (H3 numbering is
used throughout the manuscript unless otherwise stated) and mutant
A/turkey/Turkey/1/2005 (H5N1) (tyTy) viruses containing Δ133,
Ile155Thr, Ser125Asn and combinations of them were generated by
reverse genetics following PCR mutagenesis of their respective wild-
type HA cDNAs. All recombinant viruses in this study were propa-
gated and puriﬁed from embryonated chicken eggs.
Receptor binding properties of H5 mutants evaluated by biolayer
interferometry (BLI)
BLI experiments with mutant clade 1 VN1194 viruses indicated
that Ser227Asn (Fig. 1b) and Asn186Lys (Fig. 1f) mutations, located
in close proximity to the receptor binding site, reduce avian
receptor binding (red curves) by 1200- and 80-fold respec-
tively, compared to the wild-type VN1194 (Fig. 1a). For the
Ser227Asn mutant, binding to human receptor (blue curves) is
weak with an avidity slightly less than wild-type VN1194. In
contrast, human receptor binding by the Asn186Lys mutant
increases 120-fold. Gln196Arg and Gly143Arg substitutions,
located further away from the receptor binding site, modify
receptor binding of the VN1194 HA in very similar ways (Fig. 1c
and g). Both substitutions in isolation increase virus avidity for
human receptor by 120- to 180-fold. However, avidities for avian
receptor are almost the same as those of wild-type VN1194.
Introduction of the double substitutions Ser227Asn/Gln196Arg
and Asn186Lys/Gly143Arg, identiﬁed in viruses isolated from
humans (Yamada et al., 2006), indicated that the weakened avian
receptor binding that resulted from Ser227Asn or Asn186Lys
mutations alone can be partially restored by the second substitu-
tions. In the case of the Ser227Asn/Gln196Arg combinat-
ion, avian receptor binding decreases 50-fold relative to the
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Fig. 1. Estimates of the afﬁnity and speciﬁcity of receptor binding by mutant H5 inﬂuenza viruses. Binding of sialylglycopolymers containing α-2,3-sialolactosamine (3SLN,
avian receptor analogue, red) and sialylglycopolymers containing α-2,6-sialolactosamine (6SLN, human receptor analogue, blue) by VN1194 mutants (b–d, f–h) and tyTy
mutants (j–l) was characterised by biolayer interferometry (BLI) as detailed before (Lin et al., 2012). For comparison, data for wild-type VN1194 (a) and tyTy (i) viruses and
theoretical binding curves for an aerosol transmissible H5 mutant HA (e) (Xiong et al., 2013a) are included.
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VN1194 wild-type as opposed to the 1200-fold decrease result-
ing from the Ser227Asn single mutation. For the Asn186Lys/
Gly143Arg double mutant, avian receptor binding decreases
4-fold relative to wild-type in comparison with the 80-fold
decrease in binding by the mutant containing only the Asn186Lys
substitution. The second substitutions were also found to increase
human receptor binding compared with the Ser227Asn or
Asn186Lys single mutants (Fig. 1d and h). The Ser227Asn/
Gln196Arg mutant virus has the same avidity towards human
receptor as that of the Gln196Arg single mutant, suggesting that
increased human receptor binding by the double mutant is mainly
brought about by the Gln196Arg substitution (Fig. 1c and d).
By contrast the afﬁnity for human receptor of the Asn186Lys/
Gly143Arg mutant increases compared with either of the two
single mutants; the combined effect gives rise to a 104-fold gain
in human receptor binding avidity compared to the VN1194 wild-
type (Fig. 1f, g and h), indicating that both Asn186Lys and
Gly143Arg substitutions have a role in improving human receptor
binding.
tyTy H5 is the prototype of clade 2.2 viruses that are now
established in Egypt. BLI analyses demonstrated that it binds to
avian receptor with similar avidity to VN1194. However, it has
signiﬁcantly greater avidity for human receptor (Fig. 1i), which
may be partly attributed to the absence of a glycosylation site at
158, previously shown to be important for H5 aerosol transmission
(Herfst et al., 2012; Imai et al., 2012). Three mutations, a deletion
of residue 133 (Δ133), and two amino acid substitutions, Ile155Thr
and Ser125Asn were originally identiﬁed as Egyptian strain spe-
ciﬁc mutations. For HAs containing these mutations BLI analyses
indicate that single mutants – Δ133 (Fig. 1j) and Ile155Thr
(Fig. 1k), have little effect on avian receptor binding compared to
the wild-type tyTy H5 virus (Fig. 1i). Human receptor binding by
Δ133 also remains unchanged relative to wild-type tyTy, but there
is a 40-fold decrease in human receptor binding by the Ile155Thr
single mutant. Interestingly, when Δ133 and Ile155Thr were
introduced simultaneously into tyTy H5, a small increase in avian
receptor binding (3-fold) and a signiﬁcant increase of human
receptor binding (100-fold) were observed (Fig. 1l). In contrast,
the other Egyptian strain speciﬁc substitution, Ser125Asn alone or
in combination with the Δ133 and/or Ile155Thr mutations has no
inﬂuence on the receptor binding properties (Supplementary
Fig. 1a–d) probably reﬂecting its relatively distant location from
the receptor binding pocket (Supplementary Fig. 2a).
The structures of the H5 mutant HAs and the complexes that they
form with avian and human receptors
BLI analyses indicate that the clade-speciﬁc mutations in
VN1194 and tyTy HAs have different effects on human and avian
receptor binding. The Ser227Asn/Gln196Arg and Asn186Lys/
Gly143Arg mutants of VN1194 have increased binding for human
receptors but reduced binding for avian receptors. In contrast, the
tyTyΔ133/Ile155Thr mutant exhibits increased binding for human
receptor with little effect on binding of avian receptor. In order to
understand the molecular basis of these differences in receptor
binding, crystal structures of VN1194 Ser227Asn/Gln196Arg,
Asn186Lys and tyTy Δ133/Ile155Thr mutant HAs in complex with
receptor analogues were determined by X-ray crystallography. The
crystal structure of an unbound form of the VN1194 Asn186Lys/
Gly143Arg mutant was also determined, but the crystal was
unsuitable for ligand soaking experiments. Nevertheless, this
structure conﬁrms that the Gly143Arg substitution is 15 Å away
from the receptor binding site (Supplementary Fig. 2b), and is thus
unlikely to affect the binding mode of receptors directly. Its
contribution to receptor binding is likely to be electrostatic.
Human receptors bound by the VN1194 Ser227Asn/Gln196Arg
(Fig. 2b) and Asn186Lys (Fig. 2c) mutants and the tyTy Δ133/
Ile155Thr mutant (Fig. 2e) adopt binding modes similar to those of
their respective wild-type HAs (Fig. 2a and d) (Xiong et al., 2013a)
(also see Supplementary Fig. 4a–c) and to each other, despite
exhibiting signiﬁcant increases in human receptor binding. The
binding mode adopted by human receptors bound to the three
mutant HAs is characterised by the face-on orientation (in relation
to the view in Fig. 2) of Gal-2, the cis glycosidic bond between Sia-1
and Gal-2, and by the receptor exiting the site over the 130-loop.
This last characteristic is in marked contrast to the vertical
trajectory of exit observed for the human receptor bound to HAs
of pandemic H1 (Gamblin et al., 2004; Xu et al., 2012), H2 (Liu
et al., 2009) and H3 (Eisen et al., 1997) viruses, and by that of H5
transmissible-mutant (Fig. 2f) (Xiong et al., 2013a).
The human receptor complexes of the two VN1194 mutant HAs
also illustrate that the bound receptors are in close proximity
to the substitutions Ser227Asn and Asn186Lys, whereas the
Gln196Arg substitution is located 17 Å away from the nearest
atom of the receptor. Thus, as with the Gly143Arg substitution, the
Gln196Arg substitution is also likely to enhance receptor binding
electrostatically, consistent with the observation that both sub-
stitutions increase the net-charge of HA by þ1 and have similar
enhancing effects in virus binding assays (compare Fig. 1c and g).
In the tyTy Δ133/Ile155Thr human receptor complex, bound
receptor is also shown close to the site of the deleted Ala-133
and the Ile155Thr substitution.
The VN1194 mutants – Ser227Asn/Gln196Arg and Asn186Lys
also exhibit signiﬁcant decreases in avian receptor binding in BLI
analyses. Their avian receptor complex structures (Fig. 3b and c)
show that both mutants bind avian receptor in a fashion similar to
that observed for avian receptors bound to the HAs of pandemic
viruses and of the H5 aerosol transmissible-mutant (Fig. 3f) (Xiong
et al., 2013a) (also see Supplementary Fig. 4d and e). The Sia-1-
Gal-2 glycosidic linkages in the two mutant-bound avian receptors
are in cis rather than the trans conformation that is typical for
avian receptor bound to wild-type H5 HAs (Fig. 3a and d) (Xiong et
al., 2013a). Due to this difference in linkage conformation, Gal-2 in
the avian receptors bound by the Ser227Asn/Gln196Arg and
Asn186Lys mutants, is rotated 1101 about the 2,3 linked glyco-
sidic bond relative to Gal-2 in the wild-type H5 avian receptor
complexes (Fig. 3a and d), making Gal-2 in the mutant bound
avian receptor appear face-on (in relation to the view in Fig. 3).
Unlike the VN1194 Ser227Asn/Gln196Arg and Asn186Lys
mutants, the tyTy Δ133/Ile155Thr mutant shows a slight increase,
rather than loss, in avian receptor binding. Consistent with this
observation, avian receptor is found to bind in the same mode
(Fig. 3e) as that found in the wild-type tyTy H5 avian receptor
complex (Fig. 3d) – a trans-glycosidic linkage between Sia-1 and
Gal-2 and an edge-on orientation for Gal-2 (in relation to the view
in Fig. 3) (also see Supplementary Fig. 4f).
The importance of interactions between Gln-226 and Asn-186 for
avian receptor binding
As described above, the α-2,3-glycosidic bond between Sia-1
and Gal-2 of the avian receptors bound to the Ser227Asn/
Gln196Arg (Fig. 3b) and Asn186Lys (Fig. 3c) mutants of VN1194
adopts an unusual cis linkage that is usually found in avian
receptors bound to HAs derived from pandemic viruses. Structural
analyses of the receptor binding sites show that the trans- to cis-α-
2,3-glycosdic linkage switch coincides with loss of a hydrogen
bond network that connects Asn-186 to Gln-226 in wild-type HA.
When avian receptor is bound to wild-type H5 HA, the side-chain
of Gln-226 is 1 Å higher in the site by comparison with its
position in the un-liganded structure (in a structural alignment
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with an RMSD¼0.23 Å on Cα atoms), and forms a hydrogen bond
with the 4-hydroxyl of Gal-2 in the receptor (Fig. 4a). The higher
position of Gln-226 in the wild-type avian receptor complex
appears to be further stabilised by an indirect hydrogen bond
between Asn-186 and Gln-226 which is bridged through a con-
served water molecule (Fig. 4b). Formation of this hydrogen bond
also results in 1 Å movement of the Asn-186 side-chain by
comparison with its position in the un-liganded structure
(Fig. 4a). In both the Ser227Asn/Gln196Arg (Fig. 4c) and Asn186Lys
(Fig. 4d) mutants, the stabilising hydrogen bond between Asn-186
and Gln-226 is lost, either due to loss of the asparagine side-chain
as a result of the Asn186Lys substitution, or to an altered Asn-186
side-chain rotamer inﬂuenced by the nearby Ser227Asn substitu-
tion. As a consequence, Gln-226 in both mutants adopts a lower
position in the site relative to its position in the wild-type avian
receptor complex but similar to that in the unliganded wild-type
structure (grey sticks in Fig. 4c and d). In this ‘lower’ position it is
unable to facilitate binding of avian receptor in the trans-con-
formation, and a distorted binding mode results in which the avian
receptor adopts a cis-conformation. Although both Ser227Asn
and Asn186Lys mutations switch the bound avian receptor to a
cis-conformation, without changing the human receptor binding
mode, they alter receptor afﬁnities to different extents. Compared
to the Ser227Asn mutant (Fig. 1b), the Asn186Lys mutant virus
has higher avidity for both human and avian receptors (Fig. 1f)
achieving similar levels to those observed for the Ser227Asn/
Gln196Arg double mutant virus (Fig. 1d). Given that residue 186
does not contact any part of the receptor, it is likely that the
Asn186Lys substitution makes an electrostatic contribution to
compensate for the loss of avian receptor afﬁnity by addition of
positive charge in a similar manner to the Gly143Arg and the
Gln196Arg substitutions.
Enhancement of human and avian receptor binding by the double
mutant Δ133/Ile155Thr of clade 2 HA
BLI analyses show that virus bearing the Δ133/Ile155Thr
double mutant HA (Fig. 1l) has higher avidity for both avian and
human receptors than wild-type HA. Neither mutation alone in-
creases afﬁnity for either human or avian receptor (Fig. 1j and k).
Crystallographic analysis of the double mutant reveals that the
structure of the sialic acid binding pocket, near residue 133,
changes signiﬁcantly compared to the structure of wild-type tyTy
HA. (see Fig. 5a and b). Firstly, the protrusion at residue 133 in the
Fig. 2. Structures of the receptor binding sites of mutant and wild-type HAs in complex with human receptor analogue as determined by X-ray crystallography. Human
receptors bound to HAs of the VN1194 Ser227Asn/Gln196Arg (b), Asn186Lys (c) and tyTy Δ133/Ile155Thr (e) mutants are shown. Four conserved structural elements of the
site: 190-helix, 220-loop, 130-loop and 150-loop are in ribbon representation and are labelled. The locations of the amino acid substitutions, together with Gln-226 are
indicated. The α-carbon atoms of Arg-196 and the site of deletion, Ala-133 (Δ133, amino-nitrogen of Gly-134), are shown as spheres. The sugar components of the receptor
analogues are coloured sialic acid (Sia-1, yellow), galactose (Gal-2, blue) and N-acetylglucosamine (NAG-3, red). Human receptor complexes formed by the Ser227Asn/
Gln196Arg (b) and Asn186Lys (c) mutant HAs show electron density for Sia-1 and Gal-2 (Supplementary Fig. 3a and b). The Δ133/Ile155Thr mutant HA–human receptor
complex shows good electron density for Sia-1, Gal-2 and NAG-3 (Supplementary Fig. 3c). The directions of the α-2,6-glycosidic bonds are indicated by arrows. Note that all
human receptors are bound in cis-conformation. For comparison, complexes of human receptors with wild-type VN1194 (a), wild-type tyTy (d), and aerosol transmissible-
mutant HAs (f) described before (Xiong et al., 2013a) are shown.
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130-loop is lost as a result of the deletion. Secondly, because of the
Ile155Thr substitution, the hydrophobic surface, formed jointly by
the side-chain of Ile-155 and the protruding Ala-133 in wild-type
HA, is lost. In both the avian and human receptor complexes of
Δ133/Ile155Thr mutant, by comparison with the wild-type, two
additional water molecules are observed in the vicinity of the
mutant residues. They are located near the polar 4-hydroxyl and
5-acetamido groups of bound Sia-1, irrespective of the receptor
type (Fig. 5a and b). ‘Wat-1’ forms hydrogen bonds with the 4-
hydroxyl of Sia-1, and with ‘Wat-2’. Thus the combination of Δ133
and Ile155Thr mutations creates a more polar environment for the
two extra water molecules. The interactions made by these water
molecules likely contribute to the higher afﬁnity for both human
and avian receptors. Comparison of the wild-type tyTy structure
with the structure of the Δ133/Ile155Thr receptor complexes
suggests that the presence of either Ala-133 or Ile-155 would
restrict the occupancy of these waters due to their close proximity
to the water binding sites. Therefore, both substitutions must
occur together to allow the water binding necessary for enhanced
afﬁnities.
Discussion
We have carried out structural studies on the HAs of a number
of H5 mutants that were isolated from infected humans in
Vietnam and Egypt to explain differences in their receptor binding
properties. Our results show that mutant VN1194 viruses with
HAs containing Ser227Asn or Asn186Lys substitutions, have lower
avidity than wild-type virus for avian receptor. This is a result of
the loss of a hydrogen-bond network, that in wild-type HA links
Gln-226 to Asn-186, and positions Gln-226 about 1 Å higher than
in un-liganded HA, to form a hydrogen bond with the 4-OH of Gal-
2 of the receptor. Instead, in the mutants, Gln-226 remains lower
in the site and the interaction with Gal-2 is not observed. In
addition, the α-2,3 glycosidic linkage between Sia-1 and Gal-2,
adopts a cis conﬁguration in the mutant complex rather than the
trans conformation that is characteristic of avian HA-avian recep-
tor complexes (Fig. 4). The structural studies with the Δ133/
Ile155Thr mutant of tyTy HA reveal a more polar environment
near the 130-and 150-loops (Fig. 5), that results from the loss of
the hydrophobic surface formed by the side-chains of Ala-133 and
Ile-155. These changes correlate with increased avidity for both
human and avian receptors.
None of the substituted residues in the mutants we have
characterised make direct interactions with the receptors; they
appear to have their effects by perturbing the biochemical proper-
ties of the receptor binding pocket. Two of the substitutions
Gly143Arg and Gln196Arg are distant from bound receptor (see
Supplementary Fig. 2b). They appear to increase avidity for
receptor electrostatically by the introduction of positive charge.
Indeed, together with Asn186Lys, which also increases the net-
charge of HA but is closer to bound receptor, the basic substitu-
tions Gly143Arg and Gln196Arg appear to alter the avidity for
Fig. 3. Structures of the receptor binding sites of mutant and wild-type HAs in complex with avian receptor analogue as determined by X-ray crystallography. Avian
receptors bound to the VN1194 Ser227Asn/Gln196Arg (b), Asn186Lys (c) and tyTy Δ133/Ile155Thr (e) mutant HAs are shown. The images of the receptor binding sites
are rotated through 601 about a vertical axis relative to Fig. 2. The structure of the Ser227Asn/Gln196Arg avian receptor complex shows density for Sia-1 and Gal-2
(Supplementary Fig. 3d), and the avian receptor complexes with Asn186Lys and Δ133/Ile155Thr mutant HAs show electron density for all 3 sugars of the bound receptor
(Supplementary Fig. 3e and f). The structural elements and selected residues in the receptor binding sites are indicated as in Fig. 2. For comparison, avian receptors bound to
wild-type VN1194 (a), wild-type tyTy (d), and aerosol transmissible-mutant (f) are shown. The directions of the α-2,3-glycosidic bonds are indicated by arrows. Note that the
avian receptors bound to the VN1194 Ser227Asn/Gln196Arg mutant (b), the Asn186Lys (c) and the aerosol transmissible-mutant (f) HAs are in cis-conformation and the wild-
type VN1194 (a) and tyTy (d) HAs and the tyTy Δ133/Ile155Thr mutant (e) HA bind avian receptors in a trans-conformation.
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human and avian receptor to similar extents. It also appears that
mutations that increase positive charge or alter site hydration have
greater impacts on the more weakly bound receptors. Thus,
VN1194 Gln196Arg, Gly143Arg and tyTy Δ133/Ile155Thr gain
avidity for human receptor but have little effect on avian receptor
binding. These observations can be explained energetically, since
the relatively weak effects of these mutations have a greater
impact on interactions with low binding energies.
The double mutants – Ser227Asn/Gln196Arg and Asn186Lys/
Gly143Arg identiﬁed in human isolates of H5 in Southeast Asia
(Yamada et al., 2006) both have mutations (Ser227Asn or
Asn186Lys) that compromise avian receptor binding. This char-
acteristic may have been selected during human infections to
circumvent virus trapping by mucins in the human respiratory
tract that are densely decorated with avian receptors. Reduction in
avian receptor binding is one of the consequences of mutations
observed in the HAs of pandemic viruses that change binding
speciﬁcity from avian to human receptors. In the HA of the H1
pandemic virus, for example, a Glu190Asp substitution disrupts
a hydrogen bond network required for avian receptor binding
(Gamblin et al., 2004) and in H2 and H3 pandemic virus HAs, and
dramatically in the HA of experimentally transmitted H5 virus,
Gln226Leu substitutions also decrease afﬁnity for avian receptors.
However, unlike these viruses, none of the H5 mutants analysed
here have changed receptor speciﬁcity sufﬁciently to prefer human
receptor over avian receptor. The extent of the difference in
speciﬁcity has been more or less pronounced in different pan-
demic viruses suggesting that preference itself is the more
important characteristic of viruses transmissible in humans. None
of the mutations studied here have this characteristic. At the same
time retention of an ability to bind avian receptors so that they can
infect poultry efﬁciently is also likely to be important for evolution
of a mutant with the potential to transmit in humans. In this
regard, our binding and structural data suggest that the Δ133/
Ile155Thr mutant is a plausible intermediate since it has the ability
to bind avian receptors tightly while at the same time displaying
enhanced afﬁnity for human receptor. Indeed surveillance data
show that H5 viruses with HAs containing the Δ133/Ile155Thr
mutations have been isolated from both poultry and humans in
Egypt (Watanabe et al., 2011). Recently also the Δ133/Ile155Thr
mutations have been identiﬁed in clade 2.1 isolates in Indonesia
(Dharmayanti et al., 2011). The widespread distribution of H5
clade 2.2 viruses with Δ133/Ile155Thr mutations many of which
also lack glycosylation at residue 158, which is known to be
important in aerosol transmission studies in ferrets (Herfst et al.,
2012; Imai et al., 2012; Neumann et al., 2012), is a concerning
Fig. 4. Detailed comparison of wild-type and mutant VN1194 avian receptor complexes. (a) Superposition of unliganded (grey) and avian receptor complexes (green) with
wild-type VN1194 in two orientations. The different positions of Gln-226 and Asn-186 upon avian receptor binding are indicated by arrows. (b) A magniﬁed view of the wild-
type HA-avian receptor complex shows the water mediated hydrogen bonds between Gln-226, Asn-186, and the avian receptor bound in a trans conformation. (c) and
(d) Magniﬁed views of the Ser227Asn/Gln196Arg and the Asn186Lys mutant HA complexes with avian receptors. Note that as a result of the point mutation (Asn186Lys) or
the change of side-chain rotamer (Ser227Asn), the water mediated hydrogen bond between Gln-226 and Asn-186 is lost, Gln-226 is in a lower position, similar to that of Gln-
226 in the un-liganded wild-type HA (shown as grey sticks), and both mutants bind avian receptor in a cis conformation.
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feature of the current stage of evolution of highly pathogenic avian
H5 viruses.
Materials and methods
Preparation of recombinant viruses
Recombinant H5N1 viruses on A/Puerto Rico/8/34 (H1N1)
(PR8) genetic background but containing H5 HA and NA genes,
were generated by reverse genetics as previously described
(Hoffmann et al., 2000). cDNA clones of HA genes from A/
Vietnam/1194/2004 (H5N1) (VN1194) and A/turkey/Turkey/1/
2005 (H5N1) (tyTy) were subcloned into pHW2000 plasmid and
their multibasic cleavage sites (QRERRRKKR) were replaced
(QRETR). By PCR, Ser227Asn, Gln196Arg, Asn186Lys, Gly143Arg
in H3 numbering (Ser223Asn, Gln192Arg, Asn182Lys, Gly139Arg in
matured H5 HA numbering) and selected combinations Ser227-
Asn/Gln196Arg and Asn186Lys/Gly143Arg were introduced into
the VN1194 HA cDNA. Δ133, Ile155Thr and Ser125Asn (Δ129,
Ile151Thr, Ser121Asn mutations in H5 numbering) and combina-
tions of them, were introduced in tyTy HA cDNA. Eight plasmids,
each containing one of the 8 viral genes, were co-transfected into
co-cultured 293 T and MDCK cells. After 3–5 days, viruses in the
supernatants were recovered by passage in MDCK cells and then
grown in the allantoic cavity of 10-day old embryonated hen eggs.
The candidate vaccine virus NIBRG14, which possesses the HA
with modiﬁed cleavage site and neuraminidase (NA) from A/
Vietnam/1194/2004 and six internal genes of PR8, was obtained
from the National Institute for Biological Standards and Control
(Wood and Robertson, 2004). Viruses were puriﬁed by sucrose
gradient sedimentation (Skehel and Schild, 1971). The HA genes of
all recombinant viruses were sequenced before and after virus
growth in eggs, to conﬁrm their identities.
Biolayer interferometry
Virus binding to sialic acid receptors was quantitatively eval-
uated by biolayer interferometry (BLI) on an Octet RED instrument
from ForteBio (Menlo Park, CA, USA), as previously described (Lin
et al., 2012). Brieﬂy, sialylglycopolymers: α-2,3-sialyllactosamine
(3SLN, avian receptor analogue) and α2,6-sialyllactosamine (6SLN,
human receptor analogue) linked to a polyacrylamide backbone
of 30-kDa polymers containing 20 mol% receptor analogue and 5mol%
biotin were purchased from Lectinity (Moscow, Russia). Sialylglycopo-
lymers were immobilised onto streptavidin biosensors (ForteBio) at
Fig. 5. Detailed comparison of wild-type and mutant tyTy receptor complexes. (a) Superposition of the tyTy wild-type (green) and the Δ133/Ile155Thr double mutant (blue)
human receptor complexes. The region outlined is magniﬁed on the right side of the ﬁgure to show the main-chain structural differences between the wild-type and the
double mutant HAs near residue 133. The two water molecules in the receptor complex of the Δ133/Ile155Thr double mutant are shown to be close to the hydrophobic
surface (grey) formed by Ile-155 and Ala-133 in wild-type HA. (b) Superposition of the tyTy wild-type (green) and the Δ133/Ile155Thr double mutant (blue) HA-avian
receptor complexes. As in (a) the wild-type and the double mutant HAs have differences in main-chain structure near residue 133. The two water molecules in the receptor
complex of the Δ133/Ile155Thr double mutant are close to the hydrophobic surface formed by Ile-155 and Ala-133 in wild-type HA.
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0.01–0.5 μg/ml for 5min in 10 mM HEPES, pH 7.4, 150 mM NaCl,
3 mM EDTA, 0.005% Tween-20. Following a buffer wash, biosensors
were incubated with virus solution at 100 pM for 30 min to measure
the association of virus, in the presence of 10 μM oseltamivir
carboxylate (Roche) and 10 μM zanamivir (GlaxoSmithKline) to inhibit
the viral neuraminidase. Experiments were performed at 25 1C and
sample plates were agitated at 1000 RPM. Responses at equilibrium
were normalised with respect to the maximum response for virus
binding and plotted as a function of the amount of sugar immobilised
on the biosensor, calculated from the response amplitude obtained in
the sugar loading step. Experiments were performed at least in
duplicate and the data were pooled for ﬁtting. Relative afﬁnities were
estimated from apparent KDs calculated from the fractional occupancy
as previously described (Xiong et al., 2013a).
X-ray crystallography
VN1194 HAs containing Ser227Asn/Gln196Arg, Asn186Lys,
Asn186Lys/Gly143Arg, and Gln196Arg substitutions, were puriﬁed
from recombinant viruses grown in chicken eggs as published
before (Xiong et al., 2013a). tyTy Δ133/Ile155Thr HA was
expressed in Sf-9 insect cells and puriﬁed using previously
published methods (Lin et al., 2012).
VN1194 Ser227Asn/Gln196Arg, Asn186Lys, and Gln196Arg
mutant HAs were crystallised from 0.1 M HEPES/MOPS pH 7.0,
0.05 M MgCl2, 28–30% PEG 550 MME using crushed wild-type
VN1194 HA crystals as seeds.
VN1194 Asn186Lys/Gly143Arg mutant HA was crystallised from
0.1 M MOPS pH 7.0, 12% PEG 4000.
tyTy Δ133/Ile155Thr mutant HA was initially crystallised from
Bis–tris propane pH 7.5, 0.2 M K/NaPO4 (pH 7.0), 20% PEG 3350,
and crystals were improved by seeding in Bis–tris propane pH 7.5,
0.05–0.15 M K/NaPO4 (pH 7.0), 15–18% PEG 3350.
Ligand soaking experiments were performed by soaking the
crystals in crystallisation solution supplemented with 40 mM
receptor analogues for 16 hours. Crystals grown from PEG 4000
and PEG 3350 conditions were cryoprotected with 25% of ethylene
glycol prior to freezing.
Diffraction data were collected at 100 K on Diamond beamlines
or a Rigaku MicroMax-007 HF X-ray generator coupled to an R-
AXIS IVþþ detector. Diffraction images were processed in
MOSFLM (Leslie and Powell, 2007) or XDS (Kabsch, 2010), before
being scaled by Scala (Evans, 2006) in the CCP4 suite (Winn et al.,
2011). Structures were determined by molecular replacement in
Phaser (McCoy et al., 2007) using the VN1194 structure (PDB:2IBX)
(Yamada et al., 2006). Structures were built in Coot (Emsley et al.,
2010) and reﬁned in Refmac (Murshudov et al., 1997) before being
validated by MolProbity (Chen et al., 2010) to be of good quality.
Coordinates (4CQP, 4CQQ, 4CQR, 4CQS, 4CQT, 4CQU, 4CQV, 4CQW,
4CQX, 4CQY, 4CQZ, and 4CR0) are deposited in the PDB and the
crystallographic statistics are listed in Supplementary Table 1.
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